
Pro-Dex PDEX
$ 39.92
1.29%
Quarterly report 2025-Q4
added 01-29-2026
Pro-Dex Cash Conversion Cycle 2011-2026 | PDEX
Annual Cash Conversion Cycle Pro-Dex
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 193 | 195 | 225 | 209 | 170 | 137 | 144 | 150 | 108 | 122 | 180 | 184 | 176 | 115 | 97.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 225 | 97.2 | 160 |
Quarterly Cash Conversion Cycle Pro-Dex
| 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 208 | - | 213 | 188 | 191 | - | 184 | 207 | 231 | - | 197 | 220 | 227 | 96 | 195 | 175 | 184 | 91.6 | 140 | 165 | 174 | 158 | 152 | 137 | 145 | 123 | 130 | 129 | 116 | 115 | 101 | 102 | 113 | 75.8 | 92.8 | 90.7 | 84.8 | 102 | 98.9 | 97.4 | 117 | 96.2 | 106 | 124 | 149 | 139 | 182 | 191 | 232 | 177 | 213 | 169 | 138 | 148 | 158 | 151 | 133 | 123 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 232 | 75.8 | 149 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
262 | $ 19.97 | 1.17 % | $ 10.2 B | ||
|
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | ||
|
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
143 | $ 148.98 | -0.7 % | $ 3.63 B | ||
|
Ekso Bionics Holdings
EKSO
|
266 | $ 8.86 | 5.6 % | $ 179 M | ||
|
Alcon
ALC
|
134 | $ 81.1 | -0.04 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
185 | $ 36.42 | -1.43 % | $ 1.71 B | ||
|
Repro Med Systems
KRMD
|
149 | $ 5.37 | -1.47 % | $ 245 M | ||
|
Haemonetics Corporation
HAE
|
217 | $ 66.0 | 0.05 % | $ 3.32 B | ||
|
electroCore
ECOR
|
2.97 | $ 6.6 | -7.04 % | $ 36.4 K | ||
|
AngioDynamics
ANGO
|
124 | $ 10.3 | 3.16 % | $ 421 M | ||
|
InfuSystem Holdings
INFU
|
24.9 | $ 8.16 | 1.49 % | $ 168 M | ||
|
The Cooper Companies
COO
|
210 | $ 80.63 | 0.32 % | $ 16.1 B | ||
|
Masimo Corporation
MASI
|
83.7 | $ 134.6 | -1.21 % | $ 7.17 B | ||
|
Harvard Bioscience
HBIO
|
208 | $ 0.5 | -6.45 % | $ 21.2 M | ||
|
Glaukos Corporation
GKOS
|
170 | $ 117.83 | -0.95 % | $ 5.71 B | ||
|
Merit Medical Systems
MMSI
|
171 | $ 80.96 | 0.9 % | $ 4.71 B | ||
|
OraSure Technologies
OSUR
|
167 | $ 2.77 | -0.72 % | $ 206 M | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
58.7 | $ 151.01 | 1.36 % | $ 4.71 B | ||
|
LeMaitre Vascular
LMAT
|
28.7 | $ 84.27 | 0.48 % | $ 1.89 B | ||
|
Intuitive Surgical
ISRG
|
208 | $ 502.63 | -0.97 % | $ 179 B | ||
|
STERIS plc
STE
|
112 | $ 260.46 | -0.53 % | $ 25.7 B | ||
|
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | ||
|
Microbot Medical
MBOT
|
-52.9 | $ 1.83 | -1.61 % | $ 18.7 M | ||
|
Nephros
NEPH
|
161 | $ 4.45 | 1.37 % | $ 46.2 M | ||
|
Utah Medical Products
UTMD
|
280 | $ 60.82 | -1.35 % | $ 221 M | ||
|
Milestone Scientific
MLSS
|
545 | $ 0.29 | -2.9 % | $ 23.1 M | ||
|
Envista Holdings Corporation
NVST
|
79.4 | $ 23.09 | -1.2 % | $ 3.98 B | ||
|
Predictive Oncology
POAI
|
-241 | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
36.5 | $ 13.81 | 1.37 % | $ 663 M | ||
|
Becton, Dickinson and Company
BDX
|
110 | $ 202.07 | 0.49 % | $ 58.1 B | ||
|
Repligen Corporation
RGEN
|
272 | $ 151.17 | -3.33 % | $ 8.42 M | ||
|
ResMed
RMD
|
167 | $ 252.23 | -2.1 % | $ 36.8 B | ||
|
BioLife Solutions
BLFS
|
37.9 | $ 21.94 | -2.86 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
212 | $ 2.26 | -3.0 % | $ 182 M | ||
|
Retractable Technologies
RVP
|
250 | $ 0.7 | 1.3 % | $ 21 M | ||
|
STAAR Surgical Company
STAA
|
26 | $ 18.82 | -0.63 % | $ 925 M | ||
|
Teleflex Incorporated
TFX
|
183 | $ 104.28 | -1.11 % | $ 4.88 B | ||
|
West Pharmaceutical Services
WST
|
98.9 | $ 228.14 | -1.87 % | $ 16.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
63.9 | $ 12.36 | 0.73 % | $ 2.51 B |